Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.90
-0.70 (-2.97%)
Mar 10, 2026, 12:43 PM CST

Bioray Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Cash & Equivalents
154.87178.2197.02139.07126.31145.91
Upgrade
Cash & Short-Term Investments
154.87178.2197.02139.07126.31145.91
Upgrade
Cash Growth
10.20%83.68%-30.23%10.10%-13.43%-31.49%
Upgrade
Accounts Receivable
63.0854.6352.6247.1639.7526.97
Upgrade
Other Receivables
0.040.12.11.753.92.79
Upgrade
Receivables
63.1354.7454.7248.9243.6529.76
Upgrade
Inventory
55.5646.2755.9552.8945.5648.38
Upgrade
Prepaid Expenses
20.5716.177.879.292.614.04
Upgrade
Other Current Assets
0.1100.090.10.10.1
Upgrade
Total Current Assets
294.22305.39215.65250.26218.23228.18
Upgrade
Property, Plant & Equipment
223.35229.37310.82331.8229.59223.85
Upgrade
Goodwill
---1.31.31.3
Upgrade
Other Intangible Assets
0.580.861.421.951.81.82
Upgrade
Long-Term Deferred Tax Assets
2.84.714.992.552.63.16
Upgrade
Other Long-Term Assets
3.023.319.7610.7712.6717.5
Upgrade
Total Assets
523.97543.63542.65598.63466.18475.8
Upgrade
Accounts Payable
7.24.529.4912.6411.476.68
Upgrade
Accrued Expenses
-0.160.32-0.070.11
Upgrade
Short-Term Debt
---152527.2
Upgrade
Current Portion of Leases
8.486.654.146.573.775.87
Upgrade
Current Income Taxes Payable
3.12-0.10.680.85-
Upgrade
Current Unearned Revenue
8.3815.5710.613.1216.114.61
Upgrade
Other Current Liabilities
13.9916.8218.4619.8119.9721.07
Upgrade
Total Current Liabilities
41.1743.7343.167.8277.2275.54
Upgrade
Long-Term Debt
-35----
Upgrade
Long-Term Leases
42.8344.1365.6679.3424.6628.52
Upgrade
Long-Term Deferred Tax Liabilities
-0.05--00
Upgrade
Other Long-Term Liabilities
----0.37-
Upgrade
Total Liabilities
84.01122.9108.75147.16102.26104.05
Upgrade
Common Stock
300.85300.85300.85300.85268.85267.32
Upgrade
Additional Paid-In Capital
123.56133.51133.51133.5178.4572.45
Upgrade
Retained Earnings
30.251.060.0617.6417.1430.13
Upgrade
Treasury Stock
-14.17-14.17----
Upgrade
Comprehensive Income & Other
-0.53-0.53-0.53-0.53-0.52-0.52
Upgrade
Total Common Equity
439.96420.73433.9451.47363.92369.37
Upgrade
Minority Interest
-----2.38
Upgrade
Shareholders' Equity
439.96420.73433.9451.47363.92371.75
Upgrade
Total Liabilities & Equity
523.97543.63542.65598.63466.18475.8
Upgrade
Total Debt
51.3285.7869.79100.9153.4361.58
Upgrade
Net Cash (Debt)
103.5692.4327.2338.1672.8884.32
Upgrade
Net Cash Growth
108.00%239.42%-28.63%-47.65%-13.57%-43.63%
Upgrade
Net Cash Per Share
3.503.100.911.362.723.15
Upgrade
Filing Date Shares Outstanding
29.5929.5930.0929.1526.8926.73
Upgrade
Total Common Shares Outstanding
29.5929.5930.0929.1526.8926.73
Upgrade
Working Capital
253.05261.66172.55182.44141.01152.65
Upgrade
Book Value Per Share
14.8714.2214.4215.4913.5413.82
Upgrade
Tangible Book Value
439.39419.87432.47448.22360.82366.25
Upgrade
Tangible Book Value Per Share
14.8514.1914.3815.3713.4213.70
Upgrade
Buildings
229.21229.21281.8237.36226.86215.95
Upgrade
Machinery
94.1996.2697.2378.4768.7552.51
Upgrade
Construction In Progress
---39.92-0.36
Upgrade
Leasehold Improvements
2.842.842.842.842.842.84
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.